Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA.
Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjøro T, Laake P, Taskén KA, Svindland A, Eri LM, Brennhovd B, Carlsen MH, Fosså SD, Smeland SS, Karlsen AS, Blomhoff R. Paur I, et al. Among authors: smeland ss. Clin Nutr. 2017 Jun;36(3):672-679. doi: 10.1016/j.clnu.2016.06.014. Epub 2016 Jun 30. Clin Nutr. 2017. PMID: 27406859 Free article. Clinical Trial.
Erratum to 'Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma' [Eur J Cancer 170 (2022) 209-235].
Budde A, Baust K, Weinhold L, Bernstein M, Bielack S, Dhooge C, Hjorth L, Janeway KA, Jenney M, Krailo MD, Marina N, Nagarajan R, Smeland S, Sydes MR, De Vos P, Whelan J, Wiener A, Calaminus G, Schmid M. Budde A, et al. Eur J Cancer. 2022 Dec;177:208-209. doi: 10.1016/j.ejca.2022.06.053. Epub 2022 Nov 5. Eur J Cancer. 2022. PMID: 36347760 Free PMC article. No abstract available.
Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.).
Palmerini E, Reichardt P, Hall KS, Bertulli R, Bielack SS, Comandone A, Egerer G, Hansmeier A, Kevric M, Carretta E, Hansson L, Jebsen N, Eriksson M, Bruland ØS, Donati DM, Ibrahim T, Smeland S, Ferrari S. Palmerini E, et al. Among authors: smeland s. Cancer. 2023 Nov 15;129(22):3564-3573. doi: 10.1002/cncr.34964. Epub 2023 Aug 2. Cancer. 2023. PMID: 37530385
Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets.
Høland M, Berg KCG, Eilertsen IA, Bjerkehagen B, Kolberg M, Boye K, Lingjærde OC, Guren TK, Mandahl N, van den Berg E, Palmerini E, Smeland S, Picci P, Mertens F, Sveen A, Lothe RA. Høland M, et al. EBioMedicine. 2023 Nov;97:104829. doi: 10.1016/j.ebiom.2023.104829. Epub 2023 Oct 12. EBioMedicine. 2023. PMID: 37837931 Free PMC article.
Cellular uptake of vitamin A.
Blomhoff R, Senoo H, Smeland S, Bjerknes T, Norum KR. Blomhoff R, et al. J Nutr Sci Vitaminol (Tokyo). 1992;Spec No:327-30. doi: 10.3177/jnsv.38.special_327. J Nutr Sci Vitaminol (Tokyo). 1992. PMID: 1338447 No abstract available.
Binding of perlecan to transthyretin in vitro.
Smeland S, Kolset SO, Lyon M, Norum KR, Blomhoff R. Smeland S, et al. Biochem J. 1997 Sep 15;326 ( Pt 3)(Pt 3):829-36. doi: 10.1042/bj3260829. Biochem J. 1997. PMID: 9307034 Free PMC article.
99 results